[BMJ Publishing Group Ltd ESGO Annual Meeting Abstracts -...

  • Main
  • [BMJ Publishing Group Ltd ESGO Annual...

[BMJ Publishing Group Ltd ESGO Annual Meeting Abstracts - ()] Best Oral Communications/Late-Breaking Abstracts 3 – Ovarian Cancer - Phase III PAOLA-1/ENGOT-ov25 trial: olaparib plus bevacizumab as maintenance therapy in patients with newly diagnosed, advanced ovarian cancer treated with platinum-based chemotherapy plus bevacizumab

Harter, P, Mouret-Reynier, MA, Pignata, S, Cropet, C, González-Martin, A, Bogner, G, Fujiwara, K, Vergote, I, Colombo, N, Mäenpää, J, Floquet, A, El-Balat, A, Lorusso, D, Guerra Alia, EM, Fabbro,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
DOI:
10.1136/ijgc-2019-esgo.10
File:
PDF, 87 KB
Conversion to is in progress
Conversion to is failed